Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT06585202 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aclaris Therapeutics, Inc.